Document is current
Any future updates will be listed below
-
Authors
Kogias, Nikos
Geurts, Dirk E. M.
Krause, Florian
Speckens, Anne E. M.
Hermans, Erno J.
-
Funding
Funding for this research was provided by:
Radboud University Medical Center Junior researcher grant
Radboud University Medical Center
- License Information
-
More Information
Article History
Received: 16 May 2023
Accepted: 5 June 2023
First Online: 1 July 2023
Declarations
:
: The MindRest trial has been approved by the local medical ethics committee, METC Oost-Nederland (number: NL74345.091.20). The study is conducted according to the principles of the Declaration of Helsinki (6th edition, 2008) and in accordance with the Medical Research Involving Human Subjects Act (WMO). Participation is voluntary and a written informed consent is obtained from all the participants. We believe that the risks of participation are negligible. However, we will monitor for potential adverse events. Any significant modifications to the protocol will be submitted as an amendment to the medical ethics committee.
: Not applicable.
: The authors declare no competing interests.
